Paper40488994
Novel therapeutic strategies targeting infections caused by P. aeruginosa biofilm.
Lekhwar R and 4 others. Mol Biol Rep, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Novel therapeutic strategies targeting infections caused by P. aeruginosa biofilm. Papers, record 40488994. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40488994
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biofilms | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Pseudomonas Infections | Major topic |
| Humans | |
| Anti-Bacterial Agents | |
| Drug Resistance, Multiple, Bacterial | |
| Phage Therapy | |
| Antimicrobial Peptides | |
| Immunotherapy |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37771093 | Structural analysis of novel drug targets for mitigation of Pseudomonas aeruginosa biofilms. | FEMS Microbiol Rev | 2023 | https://conductscience.org/library/papers/37771093 | PubMed |
| 2 | 38501823 | Antibacterial peptide Reg4 ameliorates Pseudomonas aeruginosa-induced pulmonary inflammation and fibrosis. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/38501823 | PubMed |
| 3 | 38886583 | Bacteriophage protein Dap1 regulates evasion of antiphage immunity and Pseudomonas aeruginosa virulence impacting phage therapy in mice. | Nat Microbiol | 2024 | https://conductscience.org/library/papers/38886583 | PubMed |
| 4 | 38428090 | Bacterial profiles detected in ventilator-associated pneumonia in Japan: A systematic review. | Respir Investig | 2024 | https://conductscience.org/library/papers/38428090 | PubMed |
| 5 | 38653744 | Phage-antibiotic combinations to control Pseudomonas aeruginosa-Candida two-species biofilms. | Sci Rep | 2024 | https://conductscience.org/library/papers/38653744 | PubMed |
| 6 | 38594311 | A folate inhibitor exploits metabolic differences in Pseudomonas aeruginosa for narrow-spectrum targeting. | Nat Microbiol | 2024 | https://conductscience.org/library/papers/38594311 | PubMed |
| 7 | 38214500 | Inhibition of polymorphic MexXY-OprM efflux system in Pseudomonas aeruginosa clinical isolates by Berberine derivatives. | ChemMedChem | 2024 | https://conductscience.org/library/papers/38214500 | PubMed |
| 8 | 37795577 | Is Short-Course Antibiotic Therapy Suitable for Pseudomonas aeruginosa Bloodstream Infections in Onco-hematology Patients With Febrile Neutropenia? Results of a Multi-institutional Analysis. | Clin Infect Dis | 2024 | https://conductscience.org/library/papers/37795577 | PubMed |
| 9 | 36130230 | Less Is More? Antibiotic Treatment Duration in Pseudomonas aeruginosa Ventilator-Associated Pneumonia. | Clin Infect Dis | 2023 | https://conductscience.org/library/papers/36130230 | PubMed |
| 10 | 39224938 | Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort study. | J Antimicrob Chemother | 2024 | https://conductscience.org/library/papers/39224938 | PubMed |
| 11 | 38745145 | Evaluation of fortimicin antibiotic combinations against MDR Pseudomonas aeruginosa and resistome analysis of a whole genome sequenced pan-drug resistant isolate. | BMC Microbiol | 2024 | https://conductscience.org/library/papers/38745145 | PubMed |
| 12 | 39383099 | Comment on: Impact of adequate empirical combination therapy on mortality in septic shock due to Pseudomonas aeruginosa bloodstream infections: a multicentre retrospective cohort study. | J Antimicrob Chemother | 2024 | https://conductscience.org/library/papers/39383099 | PubMed |
| 13 | 38097907 | Biofilm formation: mechanistic insights and therapeutic targets. | Mol Biomed | 2023 | https://conductscience.org/library/papers/38097907 | PubMed |
| 14 | 39431861 | Urinary tract infections and catheter-associated urinary tract infections caused by Pseudomonas aeruginosa. | Microbiol Mol Biol Rev | 2024 | https://conductscience.org/library/papers/39431861 | PubMed |
| 15 | 37627724 | The Art of War with Pseudomonas aeruginosa: Targeting Mex Efflux Pumps Directly to Strategically Enhance Antipseudomonal Drug Efficacy. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37627724 | PubMed |
| 16 | 33147726 | Multifunctional Monoclonal Antibody Targeting Pseudomonas aeruginosa Keratitis in Mice. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/33147726 | PubMed |
| 17 | 35967851 | Multidrug-resistant Pseudomonas aeruginosa is predisposed to lasR mutation through up-regulated activity of efflux pumps in non-cystic fibrosis bronchiectasis patients. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/35967851 | PubMed |
| 18 | 35442072 | Evaluating Mono- and Combination Therapy of Meropenem and Amikacin against Pseudomonas aeruginosa Bacteremia in the Hollow-Fiber Infection Model. | Microbiol Spectr | 2022 | https://conductscience.org/library/papers/35442072 | PubMed |
| 19 | 40272253 | Monoclonal antibodies derived from B cells in subjects with cystic fibrosis reduce Pseudomonas aeruginosa burden in mice. | Elife | 2025 | https://conductscience.org/library/papers/40272253 | PubMed |
| 20 | 32931584 | The Genomic Basis of Rapid Adaptation to Antibiotic Combination Therapy in Pseudomonas aeruginosa. | Mol Biol Evol | 2021 | https://conductscience.org/library/papers/32931584 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42076093 | Functional Peptides: Comparing Synthetic and Sequence-Engineered Antibiofilm Pharmaceutics. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42076093 | PubMed |
| 41220486 | Eco-friendly nanoparticles from Fusarium solani suppress biofilms and quorum sensing in Pseudomonas aeruginosa. | Nanoscale Adv | 2026 | https://conductscience.org/library/papers/41220486 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40488994
GET https://conductscience.org/api/papers/v1/40488994/references?page=2